Jovan-Embiricos Morana 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:59 pm Sale | 2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Jovan-Embiricos Morana | 2,177,461 5.090% | -1,606,510 (-42.46%) | Filing |
| 2023-02-15 11:42 am Sale | 2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Jovan-Embiricos Morana | 3,783,971 8.300% | -2,495,742 (-39.74%) | Filing |
| 2022-02-10 4:49 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Jovan-Embiricos Morana | 6,279,713 14.300% | 6,279,713 (New Position) | Filing |